HOME >> MEDICINE >> NEWS
Researchers develop better understanding of tamoxifen resistance in breast cancer patients

Washington, D.C. A new study by researchers at Georgetown's Lombardi Comprehensive Cancer Center may have implications for the thousands of breast cancer patients who develop resistance to antiestrogen drugs such as Tamoxifen. The work is published in the June 1 issue of Cancer Research.

The study, led by Robert Clarke, Ph.D., D.Sc., professor of oncology, shows that there may be an association between the gene IRF 1 (Interferon Regulatory Factor) and breast tumor resistance to tamoxifen or other antiestrogen treatment. IRF 1 is a tumor suppressor gene not previously associated with breast cancer.

"We hope that by pinpointing the connection between IRF 1 and breast cancer, we may be able to better identify which patients will respond to antiestrogen treatment and which patients will ultimately develop antiestrogen resistance," said Clarke.

Antiestrogen therapy is currently the most effective means to manage hormone-dependent breast cancer and has the fewest serious side effects. Hormone-dependent breast cancer accounts for approximately one-third of all breast cancer cases. The most widely prescribed antiestrogen therapy is tamoxifen, which blocks the activity of the estrogen hormone in breast tissue and can increase patients' overall survival. However about a third of breast tumors that might be expected to respond (because they express receptors for estrogen) are resistant to antiestrogens from the onset of treatment, and many initially responsive tumors sooner or later become resistant.

The Lombardi researchers studied a series of antiestrogen-sensitive and antiestrogen-resistant human breast cells using a variety of different microarray technologies.

"The logical implication of our work is that by adding the protein interferon to antiestrogen therapy, we should be able to turn on the IRF 1 gene to make these tumors sensitive to antiestrogen therapy, hopefully inhibiting new breast cancers or reoccurrences
'"/>

Contact: Elizabeth McDonald
eem6@georgetown.edu
202-687-7707
Georgetown University Medical Center
9-Jun-2004


Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
8. Researchers offer emergency workers a lifeline
9. Researchers discover genetic variant that may explain why women develop M.S. more than men
10. Researchers map the sexual network of an entire high school
11. Researchers hope monkeys can provide new insights into depression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... ... ... The Los Angeles leg of the US movie premier of the Man in the Camo ... the Clive Davis Theater inside the Grammy Museum Located in downtown Los Angeles in the ... Welsh rock musician, Mike Peters (of The Alarm), his rise to fame, battle with cancer ...
(Date:7/27/2017)... ... July 27, 2017 , ... Team Novo Nordisk, the ... to the men’s pro squad as a stagiaire for the remainder of the 2017 ... debut on July 31st at the Tour of Utah. , “Every season we are ...
(Date:7/26/2017)... Miami, FL (PRWEB) , ... July 26, 2017 , ... ... caps that treat hereditary hair loss. The new Flexible Fitting Design offers a more ... of Capillus, LLC is delighted with the improvements to the home-use laser therapy caps ...
(Date:7/26/2017)... ... July 26, 2017 , ... A major challenge many labs face is a ... and a lengthy freeze dry cycle are a few common challenges that can overcome ... well as new accessories and advancements in laboratory freeze dryers that will improve quality ...
(Date:7/26/2017)... ... July 27, 2017 , ... It's time to sign up for the new One-A-Month ... says Kathy Heshelow, founder of Sublime Naturals and author of numerous books on essential oils. ... month, mailed by the 5th. , Two items are included in the ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... , July 13, 2017 It should come as ... is in the midst of a crippling opioid ... since 1999, the number of overdose deaths from opiate-based medications ... over half a million dead from 2001 to 2015". During ... and hydrocodone has similarly quadrupled, drawing a compelling link between ...
(Date:7/12/2017)... , July 12, 2017 CarpalAID is a revolutionary new ... or surgery. Carpal tunnel syndrome affects more than 8 ... twice the rate of men. The common methods of treating CTS ... with uncomfortable hand braces or gloves. ... CarpalAID is a clear patch worn ...
(Date:7/11/2017)... 2017  The global market for liquid biopsy diagnostic ... million in 2016.  Although in early stages, the global ... particular as a result of the gradual shift towards ... introduction of a significant number of new liquid biopsy ... tumor biomarkers to guide treatment decisions. ...
Breaking Medicine Technology:
Cached News: